Chiba, Japan

Nobuaki Naruse


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Nobuaki Naruse

Introduction

Nobuaki Naruse is a prominent inventor based in Chiba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral antibiotics. With a total of 2 patents to his name, Naruse continues to push the boundaries of medical science.

Latest Patents

One of Naruse's latest patents is the antiviral antibiotic BU-4344V. This innovative antibiotic is produced through the fermentation of a BU-4344V-producing strain of a new microorganism, Actinomadura parvosata subsp. kistnae ATCC No. 55076. The antibiotic is recovered and purified from the fermentation broth using extraction, chromatography, and crystallization techniques. BU-4344V has demonstrated antibacterial activity and has been found to inhibit the growth of viruses, including influenza virus type A.

Career Highlights

Nobuaki Naruse is currently employed at Bristol-Myers Squibb Company, where he continues to develop groundbreaking medical solutions. His work focuses on creating effective treatments that can combat viral infections and improve patient outcomes.

Collaborations

Throughout his career, Naruse has collaborated with notable colleagues, including Masahisa Oka and Koji Tomita. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared goals in pharmaceutical research.

Conclusion

Nobuaki Naruse's contributions to the field of antiviral antibiotics exemplify the impact of dedicated inventors in the medical industry. His work not only showcases his innovative spirit but also highlights the importance of collaboration in achieving significant advancements in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…